Similar articles

• [Cardiac resynchronization therapy with defibrillation capability: considerations on a not yet proven therapeutic superiority].

  Berisso MZ, Canonero D, Caruso D, Setti S, Domenicucci S. Berisso MZ, et al. G Ital Cardiol (Rome). 2010 Apr;11(4):295-305. G Ital Cardiol (Rome). 2010. PMID: 20677575 Review. Italian.
• Cardiac resynchronization therapy for heart failure shows great promise.

  Ovsyshcher IE, Auricchio A. Ovsyshcher IE, et al. Isr Med Assoc J. 2003 Aug;5(8):589-91. Isr Med Assoc J. 2003. PMID: 12929300 No abstract available.
• Cardiac resynchronization therapy for heart failure.

  Abraham WT, Hayes DL. Abraham WT, et al. Circulation. 2003 Nov 25;108(21):2596-603. doi: 10.1161/01.CIR.0000096580.26969.9A. Circulation. 2003. PMID: 14638522 Review. No abstract available.
• The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.

  Wilkoff BL; Dual Chamber and VVI Implantable Defibrillator trial investigators. Wilkoff BL, et al. Card Electrophysiol Rev. 2003 Dec;7(4):468-72. doi: 10.1023/B:CEPR.0000023165.20987.b1. Card Electrophysiol Rev. 2003. PMID: 15071277 Clinical Trial.
• Cardiac resynchronization therapy or atrio-biventricular pacing-what should it be called?

  Cleland JG, Nasir M, Tageldien A. Cleland JG, et al. Nat Clin Pract Cardiovasc Med. 2007 Feb;4(2):90-101. doi: 10.1038/ncpcardio0794. Nat Clin Pract Cardiovasc Med. 2007. PMID: 17245403 Review.